Explore insights and strategies for managing MG long-term.
-
-
New data indicates claseprubart improves daily function in myasthenia gravis
-
Monitoring AChR antibody levels over time may help predict MG exacerbation
-
Efgartigimod delivers rapid relief for hard-to-treat myasthenia gravis
-
Efgartigimod works faster than standard therapy for impending myasthenic crisis
-
Study shows major shift toward later-onset myasthenia gravis
-
What is the MG-ADL scale?